scholarly article | Q13442814 |
P819 | ADS bibcode | 1996PNAS...93.8225U |
P356 | DOI | 10.1073/PNAS.93.16.8225 |
P932 | PMC publication ID | 38651 |
P698 | PubMed publication ID | 8710851 |
P5875 | ResearchGate publication ID | 14491203 |
P2093 | author name string | Sinicropi D | |
Dodge AH | |||
Lazarus RA | |||
Baker DL | |||
Herzka A | |||
Shak S | |||
Toy KJ | |||
Ulmer JS | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum | Q24556580 | ||
Atomic structure of the actin:DNase I complex | Q27685392 | ||
Rapid and efficient site-specific mutagenesis without phenotypic selection | Q27860628 | ||
Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death) | Q28582503 | ||
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group | Q34290556 | ||
Actin is the naturally occurring inhibitor of deoxyribonuclease I | Q35119169 | ||
Cystic fibrosis: molecular biology and therapeutic implications | Q35319385 | ||
Structure and function of actin | Q35351237 | ||
Genomic organisation and expression of mouse deoxyribonuclease I. | Q36715989 | ||
Cystic fibrosis: a disease in electrolyte transport. | Q37942450 | ||
X-ray structure of the DNase I-d(GGTATACC)2 complex at 2.3 A resolution | Q38326595 | ||
Depolymerization of F-actin by deoxyribonuclease I | Q39779116 | ||
Actin. | Q40927517 | ||
The inhibition of bovine and rat parotid deoxyribonuclease I by skeletal muscle actin. A biochemical and immunocytochemical study | Q42084869 | ||
Distinct sites on the G-actin molecule bind group-specific component and deoxyribonuclease I. | Q42849753 | ||
The chemical synthesis of a gene coding for bovine pancreatic DNase I and its cloning and expression in Escherichia coli | Q44256987 | ||
Colorimetric determination of DNase I activity with a DNA-methyl green substrate | Q46114222 | ||
Compaction assay: a rapid and simple in vitro method to assess the responsiveness of a biopolymer matrix to enzymatic modification. | Q52507133 | ||
Investigation of the actin-deoxyribonuclease I interaction using a pyrene-conjugated actin derivative | Q52715402 | ||
The Interaction of Bovine Pancreatic Deoxyribonuclease I and Skeletal Muscle Actin | Q59663163 | ||
Localization of a vitamin-D-binding protein interaction site in the COOH-terminal sequence of actin | Q67743021 | ||
A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis | Q68062090 | ||
Interactions among serum vitamin D binding protein, monomeric actin, profilin, and profilactin | Q69936615 | ||
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis | Q72224833 | ||
DNase I increases the rate constant of depolymerization at the pointed (-) end of actin filaments | Q72371541 | ||
Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin | Q72778317 | ||
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis | Q72796879 | ||
Deoxyribonuclease I in mammalian tissues. Specificity of inhibition by actin | Q72883362 | ||
Liquefaction of viscous purulent exudates by deoxyribonuclease | Q75607550 | ||
STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY | Q76503773 | ||
Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis | Q79191483 | ||
Purification of muscle actin | Q93859477 | ||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cystic fibrosis | Q178194 |
P1104 | number of pages | 5 | |
P304 | page(s) | 8225-8229 | |
P577 | publication date | 1996-08-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Engineering actin-resistant human DNase I for treatment of cystic fibrosis | |
P478 | volume | 93 |
Q73746930 | A recombinant cytotoxic chimera based on mammalian deoxyribonuclease-I |
Q48257985 | A single amino acid substitution of Leu130Ile in snake DNases I contributes to the acquisition of thermal stability |
Q36951268 | Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth |
Q28343588 | Amphibian DNases I are characterized by a C-terminal end with a unique, cysteine-rich stretch and by the insertion of a serine residue into the Ca2+-binding site |
Q30586523 | Apoptosis-related functional features of the DNaseI-like family of nucleases |
Q33518531 | Bi-directional SIFT predicts a subset of activating mutations |
Q42930592 | Bioengineered lysozyme reduces bacterial burden and inflammation in a murine model of mucoid Pseudomonas aeruginosa lung infection |
Q40927903 | Ca2+-dependent activity of human DNase I and its hyperactive variants |
Q24308800 | Cloning and characterization of a novel human DNase |
Q41014163 | Cloning and characterization of an actin-resistant DNase I-like endonuclease secreted by macrophages |
Q42816497 | Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3). |
Q27667276 | Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity |
Q30496665 | Enhanced antimicrobial activity of engineered human lysozyme |
Q41616388 | Expression and characterization of a DNase I-Fc fusion enzyme |
Q36469691 | Functional and structural characterization of chimeras of a bacterial genotoxin and human type I DNAse |
Q33761257 | How cations can assist DNase I in DNA binding and hydrolysis |
Q46500363 | Hyperactivity of human DNase I variants. Dependence on the number of positively charged residues and concentration, length, and environment of DNA. |
Q54012100 | Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions. |
Q43685643 | Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus |
Q34493979 | LL-37 induces polymerization and bundling of actin and affects actin structure |
Q28199068 | Lupus and desoxyribonuclease |
Q28741382 | Magnesium limitation is an environmental trigger of the Pseudomonas aeruginosa biofilm lifestyle |
Q24643968 | Micro- and macrorheology of mucus |
Q48359724 | Molecular, biochemical and immunological analyses of porcine pancreatic DNase I. |
Q38317348 | Molecular, biochemical and immunological studies of hen pancreatic deoxyribonuclease I. |
Q38338553 | Mutational analysis of human DNase I at the DNA binding interface: implications for DNA recognition, catalysis, and metal ion dependence |
Q64060577 | Neutrophil extracellular traps in the central nervous system hinder bacterial clearance during pneumococcal meningitis |
Q33806208 | Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application. |
Q77151788 | Pharmacodynamics of recombinant human DNase I in serum |
Q42159685 | Rabbit DNase I: purification from urine, immunological and proteochemical characterization, nucleotide sequence, expression in tissues, relationships with other mammalian DNases I and phylogenetic analysis |
Q40116758 | Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum |
Q36237958 | Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis |
Q40871295 | Surface-localized spermidine protects the Pseudomonas aeruginosa outer membrane from antibiotic treatment and oxidative stress |
Q47576141 | Taming hyperactive hDNase I: Stable inducible expression of a hyperactive salt- and actin-resistant variant of human deoxyribonuclease I in CHO cells |
Q34897103 | The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus |
Q33586289 | Using Pulmozyme DNase treatment in lentiviral vector production |
Search more.